Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians

Ca-A Cancer Journal for Clinicians · Published 2025-05-20 · DOI 10.3322/caac.70018

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.3322/caac.70018

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Integrated bioinformatic evaluation unveils a cellular senescence gene signature as a poor prognostic factor in hepatocellular carcinoma · Clinical and Experimental Medicine · 2026 · Cites or is cited by this article
• Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma · JAMA Oncology · 2026 · Cites or is cited by this article
• Adenocarcinoma of the esophagus and gastroesophageal junction: The evolving treatment landscape for locally advanced and metastatic disease in the era of immune checkpoint inhibitors and biomarker‐driven therapeutics · Ca-A Cancer Journal for Clinicians · 2026 · Same journal
• CA turns 75: Looking at the future but never forgetting the roots · Ca-A Cancer Journal for Clinicians · 2025 · Same journal
• Regorafenib as maintenance therapy showed significant delayed progression of non‐adipocytic soft tissue sarcomas · Ca-A Cancer Journal for Clinicians · 2025 · Same journal
• Aumolertinib with carboplatin–pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open‐label, multicenter, randomized phase 3 study · Ca-A Cancer Journal for Clinicians · 2026 · Same journal
• Human papillomavirus self‐collection: The long road from scientific evaluation to implementation in screening programs · Ca-A Cancer Journal for Clinicians · 2025 · Same journal
• Data support longer recurrence‐free survival with nivolumab than with ipilimumab for stage III or IV melanoma · Ca-A Cancer Journal for Clinicians · 2026 · Same journal
• Cancer treatment and survivorship statistics, 2025 · Ca-A Cancer Journal for Clinicians · 2025 · Same journal
• Frailty in patients undergoing cancer treatment linked to significantly more adverse outcomes · Ca-A Cancer Journal for Clinicians · 2025 · Same journal